In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 222 for your search:
Trial Type:  Prevention, Genetics
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Prevention, Treatment
Status: Active
Age: 30 and over
Sponsor: Other
Protocol IDs: 940110, NCT00155389
2.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 13 to 15 at first immunization
Sponsor: Other
Protocol IDs: HPV CSP01, NCT00956553
3.

Phase: Phase IV
Type: Prevention
Status: Approved-not yet active
Age: 13 to 15
Sponsor: Other
Protocol IDs: 37207, NCT01021904
4.

Phase: Phase IV
Type: Prevention
Status: Active
Age: 15 to 25
Sponsor: Pharmaceutical / Industry
Protocol IDs: 109823, NCT01031069
5.

Phase: Phase IV
Type: Behavioral study, Prevention
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 07-0585-AE, Protocol# in Pfizer: GA30517W, NCT00937508
6.

Phase: Phase IV
Type: Natural history/Epidemiology, Prevention
Status: Active
Age: 70 and over
Sponsor: Other
Protocol IDs: 1U01AG029824-01A2, NCT01038583
7.

Phase: Phase IV
Type: Behavioral study, Prevention
Status: Active
Age: 16 to 45
Sponsor: Other
Protocol IDs: P50DA016511, NCT00664755
8.

Phase: Phase IV
Type: Prevention
Status: Active
Age: 11 to 17
Sponsor: Other
Protocol IDs: GardasilMerckGomez-Lobo, NCT01101750
9.

Phase: Phase IV
Type: Behavioral study, Prevention
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 1U01CA 159533-01, NCT01289275
10.

Phase: Phase IV
Type: Prevention
Status: Active
Age: 55 and over
Sponsor: NCI, Other
Protocol IDs: ROI10-352, R01CA138627, NCT01296672
11.

Phase: Phase IV
Type: Prevention, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 10-0933, NCT01229319
12.

Phase: Phase IV
Type: Prevention, Treatment
Status: Active
Age: 15 to 45
Sponsor: Other
Protocol IDs: 4-Chaudhuri, NCT01630954
13.

Phase: Phase IV
Type: Prevention, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ISD-FPT-01-2012, NCT01656226
14.

Phase: Phase IV
Type: Prevention
Status: Active
Age: 40-to 60
Sponsor: Other
Protocol IDs: 2008BAI57B04, NCT01698164
15.

Phase: Phase IV
Type: Prevention
Status: Approved-not yet active
Age: 18 to 26
Sponsor: Other
Protocol IDs: CIHR-MOP-125949, IIS #38265, NCT01824537
16.

Phase: Phase III, Phase II
Type: Behavioral study, Prevention
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: NURA-001-09S, NCT00960375
17.

Phase: Phase III, Phase II
Type: Behavioral study, Prevention
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: NIDA-16427-5, R01-16427-5, DPMC, NCT00132821
18.

Phase: Phase III, Phase II
Type: Behavioral study, Prevention
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 15597, 5R01AA019720-02, NCT01182766
19.

Phase: Phase III, Phase II
Type: Prevention
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: N015454-00, NCT01804595
20.

Phase: Phase III, Phase II
Type: Prevention
Status: Approved-not yet active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 0727-11-HMO, NCT01813240
21.

Phase: Phase III
Type: Prevention
Status: Active
Age: 40 to 80
Sponsor: NCI, Other
Protocol IDs: CDR0000353185, P30CA023074, UARIZ-00-0430-01, UARIZ-HSC-00142, P01CA041108, 00-0430-01, NCT00078897
22.

Phase: Phase III
Type: Prevention
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: CRUK-CRISP-1, ISRCTN47437431, EU-20717, NCT00462813
23.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 40 to 69
Sponsor: Other
Protocol IDs: UC-0104/0701 - ONCO03, ONCO-03/0701, EU-20806, NOVARTIS-FNCLCC-ONCO 03/0701, 2007-000687-24, FNCLCC-ONCO-03/0701, FNCLCC-ONCO 03/0701 - LIBER, NCT00673335
24.

Phase: Phase III
Type: Prevention, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: ACCOG-HER-PCI, ACCOG-HER-PCI, ISRCTN64624715, EU-20822, NCT00639366
25.

Phase: Phase III
Type: Natural history/Epidemiology, Prevention
Status: Active
Age: 50 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000593329, S0000D, U10CA037429, SWOG-S0000D, NCT00706121
1     
New Search